Jentashapir Journal of Health Research

Published by: Kowsar

Association Between Retroperitoneal Lymphadenectomy and Survival Benefit in the Endometrioid-Type Endometrial Carcinoma Patients

Fatemeh Cheraghi 1 , * , Mitra Modaress Gilani 2 , Fatemeh Ghaemmaghami 2 and Azamsadat Mousavi 2
Authors Information
1 Fertility, Infertility and Perinatology Research Center, Imam Khomeini Hospital, Medical Faculty, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, IR Iran
2 Vali-e-Asr Hospital, Medical Faculty, Tehran University of Medical Sciences, Tehran, IR Iran
Article information
  • Jentashapir Journal of Health Research: June 01, 2015, 6 (3); e28713
  • Published Online: June 27, 2015
  • Article Type: Research Article
  • Received: June 18, 2014
  • Accepted: December 26, 2014
  • DOI: 10.5812/jjhr.28713v2

To Cite: Cheraghi F, Modaress Gilani M, Ghaemmaghami F, Mousavi A. Association Between Retroperitoneal Lymphadenectomy and Survival Benefit in the Endometrioid-Type Endometrial Carcinoma Patients, Jentashapir J Health Res. 2015 ; 6(3):e28713. doi: 10.5812/jjhr.28713v2.

Copyright © 2015, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58(2): 71-96[DOI][PubMed]
  • 2. Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, et al. Cancer statistics, 2006. CA Cancer J Clin. 2006; 56(2): 106-30[PubMed]
  • 3. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987; 60(8 Suppl): 2035-41[PubMed]
  • 4. Creasman WT. Announcement. FIGO stages–1988 Revisions. Gynecol Oncol. 1989; 35: 125-7
  • 5. Greer BE, Koh WJ, Abu-Rustum N, Bookman MA, Bristow RE, Campos S, et al. Uterine cancers. J Natl Compr Canc Netw. 2006; 4(5): 438-62[PubMed]
  • 6. American College of O. ACOG practice bulletin, clinical management guidelines for obstetrician-gynecologists, number 65, August 2005: management of endometrial cancer. Obstet Gynecol. 2005; 106(2): 413-25[PubMed]
  • 7. Kitchener H, Redman CW, Swart AM, Amos CL. on behalf of ASTEC Study Group. ASTEC. A study in the treatment of endometrial cancer. A randomised trial of lymphadenectomy in the treatment of endometrial cancer. Gynecol Oncol. 2006; 101
  • 8. Huh WK, Straughn JJ, Kelly FJ, Kilgore LC. Endometrial carcinoma. Curr Treat Options Oncol. 2001; 2(2): 129-35[PubMed]
  • 9. Aalders JG, Thomas G. Endometrial cancer--revisiting the importance of pelvic and para aortic lymph nodes. Gynecol Oncol. 2007; 104(1): 222-31[DOI][PubMed]
  • 10. Kilgore LC, Partridge EE, Alvarez RD, Austin JM, Shingleton HM, Noojin F3, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995; 56(1): 29-33[DOI][PubMed]
  • 11. Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998; 70(2): 165-71[DOI][PubMed]
  • 12. Cragun JM, Havrilesky LJ, Calingaert B, Synan I, Secord AA, Soper JT, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005; 23(16): 3668-75[DOI][PubMed]
  • 13. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998; 71(3): 340-3[DOI][PubMed]
  • 14. Mariani A, Webb MJ, Keeney GL, Haddock MG, Calori G, Podratz KC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary? Am J Obstet Gynecol. 2000; 182(6): 1506-19[DOI][PubMed]
  • 15. Carey MS, O'Connell GJ, Johanson CR, Goodyear MD, Murphy KJ, Daya DM, et al. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium. Gynecol Oncol. 1995; 57(2): 138-44[DOI][PubMed]
  • 16. Eltabbakh GH, Piver MS, Hempling RE, Shin KH. Excellent long-term survival and absence of vaginal recurrences in 332 patients with low-risk stage I endometrial adenocarcinoma treated with hysterectomy and vaginal brachytherapy without formal staging lymph node sampling: report of a prospective trial. Int J Radiat Oncol Biol Phys. 1997; 38(2): 373-80[PubMed]
  • 17. Chan JK, Wu H, Cheung MK, Shin JY, Osann K, Kapp DS. The outcomes of 27,063 women with unstaged endometrioid uterine cancer. Gynecol Oncol. 2007; 106(2): 282-8[DOI][PubMed]
  • 18. Chan JK, Cheung MK, Huh WK, Osann K, Husain A, Teng NN, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006; 107(8): 1823-30[DOI][PubMed]
  • 19. Keys HM, Roberts JA, Brunetto VL, Zaino RJ, Spirtos NM, Bloss JD, et al. A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2004; 92(3): 744-51[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments